Contact Information: Contact: Stephen Feldschuh 212-330-8515 VP of Operations Email Contact Diane Meegan 212-330-8512 Investor Relations Email Contact
Daxor Corporation to Present at the Taglich Brothers 4th Annual Small Cap Equity Conference
Senior Management Will Meet With Investors in New York City on May 1, 2007
| Source: Daxor Corp.
NEW YORK, NY -- (MARKET WIRE) -- April 26, 2007 -- Daxor Corporation (AMEX : DXR ), a medical
instrumentation and biotechnology company, today announced that Dr. Joseph
Feldschuh, President & CEO, Stephen Feldschuh, Chief Operating Officer, &
and John Reyes-Guerra, VP for Sales and Marketing, will be participating
with 12 other companies in the exclusive Taglich Brothers Small Cap Equity
Conference at 2:15 p.m. on May 1, 2007. The event will be held at Le
Parker Meridien, New York City, where institutional investors will obtain
insight into the small-cap sector through direct interaction with company
management teams.
More information about the conference can be found at: www.taglich.com.
About Daxor
Daxor Corporation manufactures and markets the BVA-100, a semi-automated
Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use
diagnostic kit. Among nationally renowned hospitals which have purchased
the BVA-100 Blood Volume Analyzer after using it on a trial basis are The
Mayo Clinic, The Cleveland Clinic and New York University Medical Center
For More Information Contact:
For more information regarding Daxor Corporation's Blood Volume Analyzer
BVA-100, visit Daxor's website www.Daxor.com, or contact Stephen Feldschuh,
212-330-8515 (VP of Operations) stephen@daxor.com or Diane Meegan,
212-330-8512 (Investor Relations) dmeegan@daxor.com.